Article: LUNESTA(TM) Second Six-Month Study Data Confirms Findings of First Six-Month Study.

Article: LUNESTA(TM) Second Six-Month Study Results ...
Business Wire;  September 28, 2005 ;     700+ words ... ... evaluating safety and efficacy of LUNESTA also included a two-week ... placebo-controlled study of LUNESTA in patients suffering from ... findings of the first six-month study, which was published in the ... this study, nightly use of LUNESTA 3 mg resulted in statistically ...

Article: LUNESTA(TM) Brand Eszopiclone, Formerly ESTORRA, Approved ...
PR Newswire;  December 16, 2004 ;     700+ words ... ... Drug Application (NDA) for LUNESTA(TM) brand eszopiclone ... FDA's decision to not limit LUNESTA's indication to short-term use. Sepracor's six-month study was the first of its kind for ... no evidence of tolerance." LUNESTA is indicated for the treatment ...

Article: Sepracor Announces Launch Timing for LUNESTA(TM) Brand ...
PR Newswire;  April 1, 2005 ;     700+ words ... ... Drug Application (NDA) for LUNESTA on December 15, 2004. Data ... FDA's decision to approve LUNESTA for long-term use. Sepracor's six-month study was the first of its kind ... Development at Sepracor. "LUNESTA is the first non-narcotic ...

Article: Data Show That LUNESTA(TM) May Be Cost Effective for ...
PR Newswire;  May 17, 2005 ;     700+ words ... ... demonstrated that using LUNESTA for the treatment of ... assessed the effect of LUNESTA 3 mg versus placebo ... findings from this six-month study were combined with quality ... recorded during the six- month study. This model is based ... associated with use of LUNESTA was comparable ...

Article: LUNESTA Phase III/IV Data to Be Presented at Associated ...
Business Wire;  June 15, 2005 ;     700+ words ... ... 2005. The four posters of LUNESTA data will be presented at the ... 2/3 Results of studies of LUNESTA will also be presented orally ... Response Across a Twelve-Month Study of Nightly Eszopiclone in Patients ... 15 p.m., Room 205/207 LUNESTA is a new non-benzodiazepine ...

Article: Sepracor Submits LUNIVIA(R) (LUNESTA(R) in U.S.) Marketing ...
Business Wire;  July 27, 2007 ;     700+ words ... ... evaluating data from our studies of LUNESTA with long-term use and in ... addition to the studies of LUNESTA in patients with insomnia and ... of its Pan-European six-month study of eszopiclone co-administered ... and in relapse prevention. LUNESTA has been commercially available ...

Article: LUNESTA(TM) Now Widely Available by Prescription to Treat ...
PR Newswire;  April 7, 2005 ;     700+ words ... ... Sepracor Inc. today announced that LUNESTA(TM) (eszopiclone 1 mg, 2 mg and 3 ... prescription in most pharmacies nationwide. LUNESTA is the first and only sleep aid (prescription ... for long-term treatment of insomnia. LUNESTA is the first treatment in its class that ...